Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VCAM1 | P19320 | 13/20 | 0.59 |
| ▸ | HPN | P05981 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.56 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.56 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.43 |
| ▸ | GLRA3 | O75311 | 1/20 | 0.42 |
| ▸ | GLRB | P48167 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.42 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL648287 | 0.80 | ALOX15 (0.63) | VCAM1HPNMAPTALOX15SIRT5 | |
| SCHEMBL21241676 | 0.79 | VCAM1 (0.64) | VCAM1HPNMAPTALOX15SIRT5 | |
| SCHEMBL8309788 | 0.78 | VCAM1 (0.55) | VCAM1HPNMAPTALOX15SIRT5 | |
| SCHEMBL646329 | 0.78 | HPN (0.59) | VCAM1HPNMAPTALOX15SIRT5 | |
| SCHEMBL647467 | 0.76 | ALOX15 (0.68) | VCAM1HPNMAPTALOX15SIRT5 | |
| SCHEMBL645860 | 0.76 | ALOX15 (0.68) | VCAM1HPNMAPTALOX15SIRT5 | |
| SCHEMBL14037559 | 0.76 | VCAM1 (0.70) | VCAM1HPNMAPTALOX15SIRT5 | |
| SCHEMBL11654078 | 0.76 | TSHR (0.66) | VCAM1MAPTGPR55GLRA3GLRB | |
| SCHEMBL10685643 | 0.75 | HPN (0.66) | VCAM1HPNMAPTALOX15SIRT5 | |
| SCHEMBL7699048 | 0.75 | VCAM1 (0.56) | VCAM1HPNMAPTALOX15SIRT5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2070919-B1 | SPIROQUINONE COMPOUND AND PHARMACEUTICAL COMPOSITION | HYKES LAB LLC (JP) | 2012-10-10 | — | — | EP | disclosed |
| US-8119686-B2 | Spiroquinone compound and pharmaceutical composition | HYKES LABORATORIES LLC (JP) | 2012-02-21 | — | — | US | disclosed |
| US-20100056613-A1 | SPIROQUINONE COMPOUND AND PHARMACEUTICAL COMPOSITION | HYKES LABORATORIES LLC (JP) | 2010-03-04 | — | — | US | disclosed |
| EP-2070919-A1 | SPIROQUINONE COMPOUND AND PHARMACEUTICAL COMPOSITION | Hykes Laboratories LLC (JP) | 2009-06-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100056613-A1 | SPIROQUINONE COMPOUND AND PHARMACEUTICAL COMPOSITION | NR1H2, NR1H3, APOB | VCAM1 1760/4885HPN 3356/4885MAPT 4362/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.